These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1989642)
21. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro. Danhauser S; Berdel WE; Schick HD; Fromm M; Reichert A; Fink U; Busch R; Eibl H; Rastetter J Lipids; 1987 Nov; 22(11):911-5. PubMed ID: 3444384 [TBL] [Abstract][Full Text] [Related]
22. Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3. Houlihan WJ; Lee ML; Munder PG; Nemecek GM; Handley DA; Winslow CM; Happy J; Jaeggi C Lipids; 1987 Nov; 22(11):884-90. PubMed ID: 2832680 [TBL] [Abstract][Full Text] [Related]
23. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712 [TBL] [Abstract][Full Text] [Related]
24. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide. Jakubowski A; Olszanecki R; Chlopicki S J Physiol Pharmacol; 2004 Jun; 55(2):409-21. PubMed ID: 15213362 [TBL] [Abstract][Full Text] [Related]
26. The role of intracellular free calcium mobilization in the mechanism of action of antitumour ether lipids SRI 62-834 and ET18-OMe. Lohmeyer M; Workman P Biochem Pharmacol; 1993 Jan; 45(1):77-86. PubMed ID: 8424826 [TBL] [Abstract][Full Text] [Related]
27. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis. Biancone L; Cantaluppi V; Boccellino M; Bussolati B; Del Sorbo L; Conaldi PG; Albini A; Toniolo A; Camussi G Am J Pathol; 1999 Nov; 155(5):1731-9. PubMed ID: 10550329 [TBL] [Abstract][Full Text] [Related]
28. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro. Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414 [TBL] [Abstract][Full Text] [Related]
29. Stimulation of neutrophil adherence to vascular endothelial cells by histamine and thrombin and its inhibition by PAF antagonists and dexamethasone. Watanabe M; Yagi M; Omata M; Hirasawa N; Mue S; Tsurufuji S; Ohuchi K Br J Pharmacol; 1991 Jan; 102(1):239-45. PubMed ID: 2043925 [TBL] [Abstract][Full Text] [Related]
30. Effects of ether lipid 1-O-octadecyl-2-methoxy-rac-glycero- 3-phosphocholine and its analogs PAF and CPAF on the release of nitric oxide in primary cultures of rat astrocytes. Cardile V; Jiang X; Renis M; Bindoni M Brain Res; 1996 Apr; 715(1-2):98-103. PubMed ID: 8739627 [TBL] [Abstract][Full Text] [Related]
31. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility. Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979 [TBL] [Abstract][Full Text] [Related]
32. The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin. Dixon EJ; Wilsoncroft P; Robertson DN; Page CP Br J Pharmacol; 1989 Jul; 97(3):717-22. PubMed ID: 2758238 [TBL] [Abstract][Full Text] [Related]
33. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086. Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938 [TBL] [Abstract][Full Text] [Related]
34. Effect of platelet activating factor and its antagonist on the mucociliary clearance of the eustachian tube in guinea pigs. Rhee CK; Jeong PS; Kim YH; Chung PS; Jung TT Ann Otol Rhinol Laryngol; 1999 May; 108(5):453-8. PubMed ID: 10335705 [TBL] [Abstract][Full Text] [Related]
35. Elevation of leukemic cell intracellular calcium by the ether lipid SRI 62-834. Lazenby CM; Thompson MG; Hickman JA Cancer Res; 1990 Jun; 50(11):3327-30. PubMed ID: 2334926 [TBL] [Abstract][Full Text] [Related]
36. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914 [TBL] [Abstract][Full Text] [Related]
37. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Bussolati B; Biancone L; Cassoni P; Russo S; Rola-Pleszczynski M; Montrucchio G; Camussi G Am J Pathol; 2000 Nov; 157(5):1713-25. PubMed ID: 11073830 [TBL] [Abstract][Full Text] [Related]
38. B-cell activation and regulation of immunoglobulin synthesis by platelet activating factor. Mazer BD; Sawami H; Franklin R; Gelfand EW Neth J Med; 1991 Oct; 39(3-4):244-53. PubMed ID: 1791887 [TBL] [Abstract][Full Text] [Related]
40. The effects of platelet-activating factor on the secretion of interleukin-8 and growth-regulated oncogene alpha in human immortalized granulosa cell line (GC1a). Kawano Y; Furukawa Y; Fukuda J; Matsumoto H; Yuge A; Narahara H Am J Reprod Immunol; 2007 Nov; 58(5):434-9. PubMed ID: 17922696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]